NeoGenomics

cancer genetics diagnostic testing company based in Fort Myers, Florida, USA

NEO Nasdaq SEC CIK 1077183
Follow NeoGenomics Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $209.3M +11.4% vs same quarter last year
Net income −$7.5M +72.2% vs same quarter last year
EPS, diluted -
Operating cash flow −$8.9M −200% vs same quarter last year
Revenue by quarter
$172M
$168M
$181.3M
$187.8M
$190.2M
$186.7M
$201.7M
$209.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$250M$0$250M$500M$750MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$727.3M−$108M
FY24$660.6M−$79M
FY23$591.6M−$88M
FY22$509.7M−$144M
FY21$484.3M−$8M
FY20$444.4M$4.2M
FY19$408.8M$8M
FY18$276.7M$2.6M
FY17$240.3M−$396K
FY16$231.8M−$6.1M
FY15$5M−$2.5M
FY14$5M$1.1M
FY13$5M$2M
FY12$5M$65K
FY11-−$1.2M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−150%−100%−50%0%50%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2543.2%−15.9%−14.8%
FY2443.9%−13.9%−12%
FY2341.3%−18.2%−14.9%
FY2236.9%−30.9%−28.3%
FY2138.6%−24.5%−1.7%
FY2041.8%−3.1%0.9%
FY1948.1%3.2%2%
FY1846%3.6%1%
FY1742.4%1.2%−0.2%
FY1642.3%0.9%−2.6%
FY15-−112.7%−50.7%
FY14-44.4%22.6%
FY13-63.5%40.7%
FY12-24.2%1.3%
FY11---
Free cash flowOperating cash flow minus capital expenditure
−$100M−$50M$0$50MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$21.8M
FY24−$34M
FY23−$30.7M
FY22−$96.9M
FY21−$90.9M
FY20−$27.6M
FY19$3.3M
FY18$30.5M
FY17$4.3M
FY16$13.9M
FY15$4.2M
FY14$5.7M
FY13$216K
FY12−$3.1M
FY11−$828K
Net margin vs the sectorMedian of Industrials companies filing with the SEC
  • NeoGenomics
  • Industrials median
−75%−50%−25%0%25%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearNeoGenomicsIndustrials median
FY25−14.8%2.5%
FY24−12%3.3%
FY23−14.9%3.7%
FY22−28.3%3.8%
FY21−1.7%3.7%
FY200.9%0.3%
FY192%3.8%
FY181%3.9%
FY17−0.2%4%
FY16−2.6%3.8%
FY15−50.7%4.4%
FY1422.6%4.8%
FY1340.7%4.9%
FY121.3%4.6%
FY11-4.8%